Access cutting-edge hypertensive disorder treatment through this clinical trial at a research site in Columbia. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Columbia location
Preparing your pre-screening questions…
Access hypertensive disorder specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hypertensive disorder treatment provided free
Check if you qualify for this hypertensive disorder clinical trial in Columbia, SC
No-Cost Study Care
Local to Columbia
Convenient for SC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Hypertensive disorders (HD), including preeclampsia, gestational hypertension, chronic hypertension, and chronic hypertension with superimposed preeclampsia, affect around 10-20% of pregnant women in the United States and are significantly associated with maternal mortality and morbidity, particularly in the postpartum period. The prevalence of HD is on the rise in the United States and has increased from 13% in 2017 to 16% in 2019 owing to an increase in advanced maternal age, obesity, and diabetes. There are major racial disparities in HD and subsequent maternal mortality and morbidity. HD affect more than 1 in 5 delivery hospitalizations of Black women. Black women with HD are also more likely than white women with HD to have more adverse postpartum blood pressure trajectories which leads to a higher incidence of hypertension related hospital readmissions (readmission for hypertension during the first 6-weeks postpartum: 16.9% among Black women vs. 9.5% among white women, p=0.02) and cardiovascular-related adverse events. However, most of the management recommendations have been centered around blood pressure targets during the antepartum period with significantly less attention paid to the postpartum period despite evidence showing that hypertensive disorders are the most common reason for postpartum readmissions and are associated with increased maternal mortality and morbidity and a significant cost burden.
Sponsor: University of South Carolina
Yes, this clinical trial (NCT06096701) has an active research site in Columbia, SC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hypertensive disorder treatment options in Columbia, SC, this clinical trial (NCT06096701) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Columbia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hypertensive disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hypertensive disorder clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Columbia — not just this study.
Browse Pulmonary Embolism Trials in Columbia →